Skip to main content

Nifty may touch 13,640 by December 2021: Nomura

Nomura also pointed out that the September quarter earnings have beaten expectations.

Global brokerage firm Nomura is of the view that Nifty may hit the level of 13,640 by December 2021.

Nomura is of the view that the improvement in sentiment around the pandemic and improving high-frequency growth indicators and corporate earnings as the economy opens up could lead to market overlooking potential growth concerns that can emerge over time.



"Factoring in 4-5 percent risk to FY22/23 consensus earnings estimates and using 19 times on December-22 earnings, we arrive at December-21 Nifty target of 13,640, implying upside of 7 percent from the current levels. Upside risk to our target multiple in the near-term remains, on the back of strong capital flows," said Nomura in a note on November 12.

Nomura thinks We think capital flows resulting from improved risk sentiment will drive stocks in the near term.

The foreign brokerage firm also highlighted that the market sentiment is high due to positive reports about the coronavirus vaccine.

"News on the vaccine front has been positive over the past few days. Pfizer and RDIF (more relevant for India) have announced that their vaccines under development have demonstrated the efficacy of over 90 percent, based on interim Phase III results. This has raised hopes of the COVID-19 pandemic being contained, if not eradicated, and normalcy gradually returning to people’s lives," said Nomura.

Nomura added that the development of vaccines furthers the objective of normalisation, as it holds out the prospect of preventing infection, limiting the spread and reducing infection severity.

The development is positive for equities, Nomura said, as it improves risk sentiment against the backdrop of strong liquidity and sustained capital flows.

Nomura also pointed out that the September quarter earnings have beaten expectations.

"The Q2 earnings season has provided stability to FY21/22 earnings expectations. Post the spread of the pandemic and economic lockdowns, consensus FY21/22 earnings for Nifty were revised down by 27 percent/15 percent in Q1FY21; however, forecasts seem to have found a near-term bottom, and since Q1FY21-end, earnings estimates have been raised by 3.5 percent/4 percent for FY21/22," said Nomura.

"Consensus is now factoring in a 20 percent earnings CAGR over FY20-23, compared to a 7 percent CAGR over FY15-19. We think expectations for medium-term earnings growth are high and are premised on a strong growth revival, lower costs (including multiyear-low credit costs for banks)," Nomura added.

The foreign brokerage firm, however, pointed out that there are potential risks to current earnings estimates, mainly a slower-than-expected revival in economic growth and the adverse impact of a rise in commodity prices.

"Currently, based on bottom-up analysis, we are factoring in 4-5 percent risk to current consensus estimates for FY22/FY23," said the brokerage.

Nomura has increased weight on banks and financials and is now overweight on financials.

"In our model portfolio, we raise the weight on financials, as we expect their valuations could expand on the expectation of improving growth rates. We increase our weight on banks (increase weight in ICICI BankAxis Bank, add State Bank of India and Max Financial)," said Nomura.

On the other hand, Nomura has reduced weight on IT and pharma.

"We have reduced our weight on IT and pharma, but continue to remain overweight on these sectors, as we expect multiples to expand as earnings visibility improves," said Nomura.

"We add Sun Pharma. Our top picks are ICICI Bank, Axis Bank, HCL TechMahindra & Mahindra and Sun Pharma (all buy-rated)," Nomura said.

Disclaimer: The above report is compiled from information available on public platforms. SD Soutions advises users to check with certified experts before taking any investment decisions.

Comments

Popular posts from this blog

Tata Realty looks to list 20 million sq ft of commercial assets as REIT

  The existing land bank has potential of 20 million sq. ft commercial development in the next three to four years, says CEO Sanjay Dutt Tata Realty and Infrastructure (TRIL) is planning to list its Real Estate Investment Trust (REIT) with a portfolio of 20 million sq ft of commercial assets in the next few years. This will be done after the portfolio is expanded from present 6.2 million sq ft to 20 million sq ft via new developments and acquisitions. Sanjay Dutt, managing director and chief executive officer of TRIL told The Economic Times that the existing land bank has potential of 20 million sq ft commercial development in the next three to four years. The portfolio may also include office spaces and data centre assets. He added that his team has looked at least four proposals from developers looking to monetise their portfolios including single assets and carved-out portfolios across the country. “We are targeting a 45-50 million sq ft in commercial portf...

Max India shares fall 5% on relisting day

  Max India resumed trading on BSE and NSE on August 28. The company, earlier known as Advaita Allied Health Services Limited, is a part of the $3-billion Max Group. Even as the broader market sentiment was bullish, shares of Max India fell 5 percent on BSE on the day of its relisting. The stock debuted at Rs 80 on BSE but fell 5 percent soon to touch its lower price band at Rs 76 on August 28. Max India resumed trading on BSE and NSE on August 28. The company, earlier known as Advaita Allied Health Services Limited, is a part of the $3-billion Max Group. The new Max India is the holding company of Max Group’s senior-care business Antar and the skilling company Max Skill First. The relisting of Max India follows Max Healthcare’s listing last week. In a media release, the company said listings are the outcome of a comprehensive scheme announced last year that involved a series of transactions, including the demerger of KKR-backed Radiant Lifecare’s assets into Max ...

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...